CDH2 and cancer: EMT had been known to involved in cancer progression, which was often marked by decreased expression of E-cadherin (epithelial marker) and increased expression of N-cadherin and Vimentin (mesenchymal markers), and the alternations of these proteins resulted in the impairment of cell–cell adhesion and the spreading cancer cells [10].